Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at


The present invention provides vaccine compositions of attenuated dengue virus. More specifically, the attenuated virus is produced by serial passage in PDK cells. The invention also provides methods for stimulating the immune system of an individual to induce protection against all four dengue virus serotypes by administration of attenuated dengue-1, dengue-2, dengue-3, and dengue-4 virus.

Docket:WRAIR 99-14

Publication/Issued No.:6,638,514

Publication/Issue Date:2003-10-28

Categories: Vaccine

More Detail:Visit USPTO.GOVExternal link


Inventor(s):ECKELS, K.

For Licensing Opportunities, please contact the ORTA at

Last Modified Date: 16 May 2023

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at: or by telephone at (301)619-2736.